M-12 · Confidential Teaser
Active
Multi-Location Podiatry Platform
Dallas · East Texas
Structure
Asset sale · guidance provided to qualified buyers
§ 01
Overview
- Established podiatry practice operating across three Texas markets.
- Recurring foot and ankle care: office visits, routine podiatry care, orthotics, diabetic footwear, nail procedures, diagnostics, and wound-support services.
- Buyer access to both Dallas and East Texas patient markets.
- Supported by ECW operating infrastructure and multi-year CPT-level billing history.
§ 02
Investment Highlights
- Three-location platform across Dallas, Athens, and Gun Barrel City.
- FY2025 revenue of approximately $654,813.
- FY2025 pre-owner-comp operating income of approximately $188,764.
- Jan–Apr 2026 revenue of approximately $204,730 — annualized to approximately $614,191.
- 6,181 FY2025 office patient-day encounters supported by ECW CPT-level data.
- Location allocation: 48.5% Dallas · 21.7% Athens · 29.8% Gun Barrel City.
- Diversified service mix across visits, routine care, orthotics, procedures, diagnostics, and wound support.
§ 03
Buyer Opportunity
- Defined upside through clinical coverage, billing control, referral development, diabetic foot care expansion, and orthotics growth across the existing location base.
- Strong fit for an owner-operator, regional podiatry group, strategic healthcare buyer, or private practice expansion platform.
CONFIDENTIAL · This teaser is anonymized by design. Identifying detail, the full
financial package, and current process phase are released under signed NDA to qualified
buyers. All mandates are offered as asset sales. Nothing on this page is an offer to sell
securities.
Request the full package.
Serious buyers only. The desk reads every note and responds with an
NDA and next steps. Reference M-12 is attached to this inquiry automatically.
Desk line 972-839-6333 · Mon–Fri 08:30–18:00 CT · all inquiries go through the form below